HIP
EW icon

Hatteras Investment Partners’s Edwards Lifesciences EW Stock Holding History

Hatteras Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-86,532
Closed -$2.06M – 118
2015
Q1 		$2.06M Buy
+86,532
New +$1.94M 1.1% 27

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Hatteras Investment Partners's EW Position: Q2 2015 in Review

Hatteras Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2015, closing a stake of 86,532 shares — an estimated $2.06M sold.

Hatteras Investment Partners first reported a position in EW in Q1 2015 and held it in 1 quarter. The position peaked at $2.06M in Q1 2015. 579 funds tracked by Wall St. Rank hold EW as of Q2 2015.

  • Hatteras Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2015 after selling out during the quarter.
  • Hatteras Investment Partners sold 86,532 Edwards Lifesciences shares in Q2 2015, an estimated $2.06M.
  • Hatteras Investment Partners first reported a position in Edwards Lifesciences in Q1 2015 and held it in 1 quarter.
  • Hatteras Investment Partners's Edwards Lifesciences position peaked at $2.06M in Q1 2015.
  • 579 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on Hatteras Investment Partners's 13F filing for Q2 2015, filed 13 Aug 2015.